Diagnosis and treatment of deep-vein thrombosis
暂无分享,去创建一个
[1] S. Doucette,et al. Does this patient have deep vein thrombosis? , 1998, JAMA.
[2] S. Eichinger. D-Dimer Testing in Pregnancy , 2003, Pathophysiology of Haemostasis and Thrombosis.
[3] D. Ost,et al. Duration of anticoagulation following venous thromboembolism: a meta-analysis. , 2005, JAMA.
[4] L. Bressollette. Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary Embolism: The PREPIC (Prévention du Risque d’Embolie Pulmonaire par Interruption Cave) Randomized Study , 2005, Circulation.
[5] M. Prins,et al. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome , 2005, Journal of thrombosis and haemostasis : JTH.
[6] F. García-Bragado,et al. The influence of extreme body weight on clinical outcome of patients with venous thromboembolism: findings from a prospective registry (RIETE) , 2005, Journal of thrombosis and haemostasis : JTH.
[7] T. Barbui,et al. A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS) 1 , 2005, Journal of thrombosis and haemostasis : JTH.
[8] I. Greer,et al. Low molecular weight heparin in pregnancy: current issues , 2005, British journal of haematology.
[9] M. Boulvain,et al. D‐dimer levels during delivery and the postpartum , 2005, Journal of thrombosis and haemostasis : JTH.
[10] M. Kovacs,et al. The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients , 2005, Journal of thrombosis and haemostasis : JTH.
[11] S. Money,et al. Low-Molecular-Weight Heparin Versus Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients With Cancer , 2004 .
[12] G. Raskob,et al. Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis , 2004, Annals of Internal Medicine.
[13] Paolo Prandoni,et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.
[14] S. Kahn,et al. Relationship between deep venous thrombosis and the postthrombotic syndrome. , 2004, Archives of internal medicine.
[15] Jonathan Dreyer,et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. , 2003, The New England journal of medicine.
[16] J. Douketis,et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. , 2003, The New England journal of medicine.
[17] T. Baglin,et al. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study , 2003, The Lancet.
[18] M. Gent,et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.
[19] M. Prins,et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. , 2003, The New England journal of medicine.
[20] J. Douketis,et al. A Diagnostic Strategy Involving a Quantitative Latex d-Dimer Assay Reliably Excludes Deep Venous Thrombosis , 2003, Annals of Internal Medicine.
[21] G. Kovacs,et al. Combined use of clinical assessment and d‐dimer to improve the management of patients presenting to the emergency department with suspected deep vein thrombosis (the EDITED Study) , 2003, Journal of thrombosis and haemostasis : JTH.
[22] A. Folsom,et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. , 2003, Blood.
[23] M. Prins,et al. Once versus twice daily LMWH for the initial treatment of venous thromboembolism. , 2003, The Cochrane database of systematic reviews.
[24] D. Coyle,et al. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy. , 2003, Thrombosis research.
[25] M. Prins,et al. Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism , 2002, Annals of Internal Medicine.
[26] Paolo Prandoni,et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. , 2002, Blood.
[27] A. Rudd,et al. Plasma D-dimers in the diagnosis of venous thromboembolism. , 2002, Archives of internal medicine.
[28] M. Petri. Management of thrombosis in antiphospholipid antibody syndrome. , 2001, Rheumatic diseases clinics of North America.
[29] A. Forster,et al. Thrombolysis in Deep Vein Thrombosis: Is there still an Indication? , 2001, Thrombosis and Haemostasis.
[30] D. Anderson,et al. Effect of Patient Weight on the Anticoagulant Response to Adjusted Therapeutic Dosage of Low-Molecular- Weight Heparin for the Treatment ofVenous Thromboembolism , 2001, Pathophysiology of Haemostasis and Thrombosis.
[31] A. Forster,et al. Tissue plasminogen activator for the treatment of deep venous thrombosis of the lower extremity: a systematic review. , 2001, Chest.
[32] H. Bounameaux,et al. Comparison of four strategies for diagnosing deep vein thrombosis: a cost-effectiveness analysis. , 2001, The American journal of medicine.
[33] P. Prandoni,et al. Upper Extremity Deep Vein Thrombosis: Risk Factors, Diagnosis, and Management , 2001, Seminars in vascular medicine.
[34] C. Kearon. Noninvasive diagnosis of deep vein thrombosis in postoperative patients. , 2001, Seminars in thrombosis and hemostasis.
[35] M Stain,et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. , 2000, The New England journal of medicine.
[36] D. Anderson,et al. Diagnosis of deep-vein thrombosis in the year 2000 , 2000, Current opinion in pulmonary medicine.
[37] H. Eriksson,et al. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. , 2000, Archives of internal medicine.
[38] Lain,et al. A CLINICAL TRIAL OF VENA CAVAL FILTERS IN THE PREVENTION OF PULMONARY EMBOLISM IN PATIENTS WITH PROXIMAL DEEP-VEIN THROMBOSIS , 2000 .
[39] M. Prins,et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. , 2000, The Cochrane database of systematic reviews.
[40] G Leone,et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. , 1999, The New England journal of medicine.
[41] J. Hirsh,et al. Prognosis in acute pulmonary embolism , 1999, The Lancet.
[42] M. Kovacs,et al. Dalteparin in emergency patients to prevent admission prior to investigation for venous thromboembolism. , 1999, The American journal of emergency medicine.
[43] P. Wells,et al. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection. , 1998, Archives of internal medicine.
[44] M. Math,et al. Noninvasive Diagnosis of Deep Venous Thrombosis , 1998, Annals of Internal Medicine.
[45] W M O'Fallon,et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.
[46] F. Barral,et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. , 1998, The New England journal of medicine.
[47] P. Prandoni,et al. Long-term outcomes after deep venous thrombosis of the lower extremities , 1998, Vascular medicine.
[48] H. Büller,et al. Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study , 1998, BMJ.
[49] Janis Bormanis,et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management , 1997, The Lancet.
[50] O. Linder,et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. , 1997, The New England journal of medicine.
[51] P. Bossuyt,et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. , 1996, The New England journal of medicine.
[52] J. Hirsh,et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. , 1996, The New England journal of medicine.
[53] M. Gent,et al. Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis , 1995, Thrombosis and Haemostasis.
[54] Olle Linder,et al. A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism , 1995 .
[55] K. Schulman,et al. Cost-effectiveness analyses. , 1995, The New England journal of medicine.
[56] S. Schulman,et al. A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism , 1996 .
[57] J. Hirsh,et al. Accuracy of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients after Orthopedic Surgery , 1995, Annals of Internal Medicine.
[58] H. Heijboer. A Comparison of Real-Time Compression Ultrasonography With Impedance Plethysmography for the Diagnosis of Deep-Vein Thrombosis in Symptomatic Outpatients , 1994 .
[59] H. Büller,et al. A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. , 1993, The New England journal of medicine.
[60] H R Büller,et al. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. , 1992, The New England journal of medicine.
[61] H. Büller,et al. Clinical Utility of Real-Time Compression Ultrasonography for Diagnostic Management of Patients with Recurrent Venous Thrombosis , 1992, Acta radiologica.
[62] B E Hillner,et al. Optimal management of suspected lower-extremity deep vein thrombosis. An evaluation with cost assessment of 24 management strategies. , 1992, Archives of internal medicine.
[63] E. G. Moss,et al. Noninvasive diagnosis of deep vein thrombosis. , 1990, New Jersey medicine : the journal of the Medical Society of New Jersey.
[64] G. Raskob,et al. Serial impedance plethysmography in pregnant patients with clinically suspected deep‐vein thrombosis. Clinical validity of negative findings , 1990, Annals of internal medicine.
[65] G. Raskob,et al. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. , 1982, The New England journal of medicine.